RxDoctor Payments Data

Kevin Schrunk

Family Medicine · Dallas, TXNPI 1144389099

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $581 and has fallen 72.5% since, to $160 in 2021.

$1,210in general payments, 2019–2025

Across 79 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$241
  • AbbVie$235
  • Pfizer$201
  • Lilly USA, LLC$176
  • Merck$69
  • Amgen$45
  • plus $242 from 13 others

What the payments were for

  • Food & beverage$1,210100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,210 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Other family medicine in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →